Latest News and Press Releases

Die ICPO-Akkreditierung erfolgt gemäß internationalen Theranostik-Richtlinien, während die ICPO Academy for Theranostics die Partnerschaft von Anfang an stärkt. 31. Juli 2025 – Wiesbaden,...

ICPO accreditation following international theranostics guidelines and ICPO Academy for Theranostics will fuel the partnership right from start. July 31, 2025 – Wiesbaden, Germany, and Sao Paulo,...

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Market of CAR/TCR/TIL Therapies in Oncology with Confidence" directory has been added to ResearchAndMarkets.com's...

DALLAS, July 03, 2025 (GLOBE NEWSWIRE) -- The Crosetto Foundation for the Reduction of Cancer Deaths, an accredited nonprofit, issues an “urgent appeal to Members of the European Parliament and...

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals

Über 220 Experten aus aller Welt kamen zusammen, um die Zukunft der Radiotheranostik zu gestalten und bessere Behandlungsergebnisse von Krebspatienten zu ermöglichen Wiesbaden – 26. Mai 2025 – Die...

Over 220 experts from around the globe came together to shape the future of radiotheranostics for better cancer patient outcomes Wiesbaden – May 26, 2025 — The International Centers for Precision...

Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "U.S. Interventional Oncology Market Size, Share & Trends Analysis Report by Technique (Ablation Therapies, Embolization Therapies), Procedure (Tumor...

DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for...

Newly Appointed Board Chair, Philip Astley-Sparke, Brings Transatlantic Late-Stage Development, Regulatory and Commercial Expertise Strengthened Leadership and Expanded U.S. Presence Positions SynOx...